Literature DB >> 12634233

Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?

I Delèvaux1, M André, M Colombier, E Albuisson, F Meylheuc, R-J Bègue, J-C Piette, O Aumaître.   

Abstract

OBJECTIVE: To study the levels of procalcitonin (PCT) in various inflammatory states seen in an internal medicine department and to evaluate the possible discriminative role of PCT in differentiating bacterial infection from other inflammatory processes.
METHODS: PCT, C reactive protein (CRP), and white blood cell count (WBC) were measured in patients admitted to the department for fever or biological inflammatory syndrome, or both. The serum of 173 consecutive patients was analysed according to the aetiological diagnosis. The patients were divided into two groups: group I (n=60) with documented bacterial or fungal infection; group II (n=113) with abacterial inflammatory disease.
RESULTS: PCT levels were >0.5 ng/ml in 39/60 (65%) patients in group I. In group II, three patients with a viral infection had slightly increased PCT levels (0.7, 0.8, and 1.1 ng/ml) as did two others, one with crystal arthritis and the other with vasculitis (0.7 ng/ml in both cases). All other patients in group II had PCT levels <0.5 ng/ml. In this study a value of PCT >0.5 ng/ml was taken as the marker of bacterial infection (sensitivity 65%, specificity 96%). PCT values were more discriminative than WBC and CRP in distinguishing a bacterial infection from another inflammatory process.
CONCLUSION: PCT levels only rose significantly during bacterial infections. In this study PCT levels >1.2 ng/ml were always evidence of bacterial infection and the cue for starting antibiotic treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12634233      PMCID: PMC1754509          DOI: 10.1136/ard.62.4.337

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

Review 1.  Procalcitonin as a marker of the systemic inflammatory response to infection.

Authors:  K Reinhart; W Karzai; M Meisner
Journal:  Intensive Care Med       Date:  2000-09       Impact factor: 17.440

2.  Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE.

Authors:  K C Shin; Y J Lee; S W Kang; H J Baek; E B Lee; H A Kim; Y W Song
Journal:  Ann Rheum Dis       Date:  2001-10       Impact factor: 19.103

3.  Procalcitonin in early detection of postoperative complications.

Authors:  H B Reith; U Mittelkötter; E S Debus; C Küssner; A Thiede
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

4.  Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia.

Authors:  I de Werra; C Jaccard; S B Corradin; R Chioléro; B Yersin; H Gallati; M Assicot; C Bohuon; J D Baumgartner; M P Glauser; D Heumann
Journal:  Crit Care Med       Date:  1997-04       Impact factor: 7.598

5.  Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.

Authors:  O K Eberhard; M Haubitz; F M Brunkhorst; V Kliem; K M Koch; R Brunkhorst
Journal:  Arthritis Rheum       Date:  1997-07

6.  Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies.

Authors:  R Sabat; C Höflich; W D Döcke; M Oppert; F Kern; B Windrich; C Rosenberger; J Kaden; H D Volk; P Reinke
Journal:  Intensive Care Med       Date:  2001-06       Impact factor: 17.440

7.  Serum procalcitonin levels in bacterial and abacterial meningitis.

Authors:  S Schwarz; M Bertram; S Schwab; K Andrassy; W Hacke
Journal:  Crit Care Med       Date:  2000-06       Impact factor: 7.598

Review 8.  [Procalcitonin, a new marker for bacterial infections].

Authors:  F Ferrière
Journal:  Ann Biol Clin (Paris)       Date:  2000 Jan-Feb       Impact factor: 0.459

9.  Elevated serum procalcitonin levels in patients with melioidosis.

Authors:  M D Smith; Y Suputtamongkol; W Chaowagul; M Assicot; C Bohuon; S Petitjean; N J White
Journal:  Clin Infect Dis       Date:  1995-03       Impact factor: 9.079

10.  High serum procalcitonin concentrations in patients with sepsis and infection.

Authors:  M Assicot; D Gendrel; H Carsin; J Raymond; J Guilbaud; C Bohuon
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

View more
  61 in total

1.  Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis.

Authors:  Helena Brodská; Karin Malíčková; Václava Adámková; Hana Benáková; Markéta Marková Šťastná; Tomáš Zima
Journal:  Clin Exp Med       Date:  2012-05-27       Impact factor: 3.984

2.  Procalcitonin in the elderly: normal plasma concentrations and response to bacterial infections.

Authors:  T Dwolatzky; K Olshtain-Pops; A M Yinnon; D Raveh; O Rogowski; I Shapira; R Rotstein; S Berliner; B Rudensky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

Review 3.  Biomarkers for risk prediction in acute decompensated heart failure.

Authors:  A Rogier van der Velde; Wouter C Meijers; Rudolf A de Boer
Journal:  Curr Heart Fail Rep       Date:  2014-09

Review 4.  The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers.

Authors:  Marin Nishimura; Alison Brann; Kay-Won Chang; Alan S Maisel
Journal:  Curr Heart Fail Rep       Date:  2018-08

Review 5.  Diagnostic approach to patients with suspected vasculitis.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

6.  Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.

Authors:  Hakan Tanrıverdi; Tacettin Örnek; Fatma Erboy; Bülent Altınsoy; Fırat Uygur; Figen Atalay; Müge Meltem Tor
Journal:  Wien Klin Wochenschr       Date:  2015-01-14       Impact factor: 1.704

7.  The value of procalcitonin measurements in children with familial Mediterranean fever.

Authors:  Selçuk Yüksel; Mesiha Ekim; Z Birsin Ozçakar; Fatoş Yalçınkaya; Banu Acar; Derya Oztuna; Nejat Akar
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

8.  Value of procalcitonin for diagnosing perioperative pneumonia, urinary infections and superficial surgical site infections in patients undergoing primary hip and knee arthroplasty.

Authors:  Lixuan Zhang; Daozhang Cai; Hanming Guo
Journal:  Exp Ther Med       Date:  2018-05-03       Impact factor: 2.447

9.  Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis? A prospective trial.

Authors:  Sabine Faesch; Bogdan Cojocaru; Carole Hennequin; Stéphanie Pannier; Christophe Glorion; Bernard Lacour; Gérard Chéron
Journal:  Ital J Pediatr       Date:  2009-11-04       Impact factor: 2.638

10.  C-reactive protein velocity to distinguish febrile bacterial infections from non-bacterial febrile illnesses in the emergency department.

Authors:  Yael Paran; Doron Yablecovitch; Guy Choshen; Ina Zeitlin; Ori Rogowski; Ronen Ben-Ami; Michal Katzir; Hila Saranga; Tovit Rosenzweig; Dan Justo; Yaffa Orbach; Pinhas Halpern; Shlomo Berliner
Journal:  Crit Care       Date:  2009-04-08       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.